文献速递产科母胎医学

空腹血糖作为妊娠晚期晚发型妊娠期糖尿病筛查指标的研究

Fasting blood glucose as a screening measure for late-onset gestational diabetes in the third trimester.
PubMed 文献 · BJOG · 2024-07-02

在中国单中心前瞻性队列中,1130例早中孕期GDM筛查阴性的单胎孕妇于32-34孕周额外检测空腹血糖,6.3%(71/1130)空腹血糖≥5.1 mmol/L诊断为晚发型GDM并接受标准化治疗;其足月分娩巨大儿发生率和NICU转诊率仍显著高于空腹血糖<5.1 mmol/L组。

要点

  • 早中孕期GDM筛查阴性的单胎孕妇中,32-34孕周额外空腹血糖筛查可发现6.3%的晚发型GDM。
  • 晚发型GDM经标准化治疗后,足月分娩巨大儿风险仍显著高于空腹血糖正常组。
  • 晚发型GDM组新生儿NICU转诊率显著高于空腹血糖<5.1 mmol/L组。

核心结论

  • 早中孕期GDM筛查正常的单胎妊娠中,32-34孕周额外空腹血糖筛查可发现6.3%的晚发型GDM,标准化治疗后其足月妊娠巨大儿风险仍显著高于空腹血糖<5.1 mmol/L组。

研究设计与样本

  • 前瞻性队列研究,单中心(中国),纳入1130例早中孕期GDM筛查阴性的单胎妊娠孕妇,于32-34孕周额外行空腹血糖检测。

主要发现

  • 6.3%(71/1130)的参与者空腹血糖≥5.1 mmol/L,诊断为晚发型GDM。
  • 晚发型GDM中65例(91.5%)接受饮食治疗,6例(8.5%)接受胰岛素治疗。
  • 足月分娩结局比较:晚发型GDM组巨大儿发生率22.7% vs 空腹血糖<5.1 mmol/L组5.1%(aOR 5.51,95%CI 1.83-16.61,p=0.002),NICU转诊率18.3% vs 10.1%(aOR 1.94,95%CI 1.01-3.74,p=0.046),晚发型GDM组均显著更高。
  • 空腹血糖升高与孕期超重或肥胖相关(54.9% vs 34.9%,OR 2.27,95%CI 1.40-3.68,p=0.001)。

关键数值与推荐

  • 32-34孕周空腹血糖≥5.1 mmol/L诊断为晚发型GDM并接受标准化治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the positive rate of late-onset gestational diabetes mellitus (GDM) by additional fasting blood glucose (FBG) screening at 32-34 gestational weeks (GW) and analyse the perinatal outcomes of late-onset GDM after standard treatment. DESIGN: An Prospective cohort study. SETTING: Single centre in China. POPULATION: 1130 singleton pregnancies with negative GDM screening in their first and second trimester. METHODS: Additional FBG testing was performed at 32-34 GW. Pregnancies with FBG ≥5.1 mmol/L were diagnosed as GDM and received standardized treatment. Perinatal outcomes were collected and compared. MAIN OUTCOME MEASURES: Diagnosis of late-onset GDM, obstetric and neonatal outcomes. RESULTS: 6.3% (71/1130) of participants had FBG values ≥5.1 mmol/L and were diagnosed with late-onset GDM. Sixty-five (91.5%) were treated by dietary therapy and 6 (8.5%) by insulin therapy. The perinatal outcomes of full-term delivery were compared. The incidence of macrosomia (22.7% vs. 5.1%, adjusted odds ratio (aOR) 5.51, 95% confidence interval (CI) 1.83-16.61, p = 0.002) and NICU transferring (18.3% vs. 10.1%, aOR 1.94, 95% CI 1.01-3.74, p = 0.046) was significantly higher in late-onset GDM group than that in FBG <5.1 mmol/L group. Elevated FBG was associated with overweight or obesity during pregnancy (54.9% vs. 34.9%, OR 2.27, 95% CI 1.40-3.68, p = 0.001). CONCLUSIONS: 6.3% of singleton pregnancies with normal GDM screening results in the first and second trimester were found to have late-onset GDM by additional FBG screening at 32-34 GW, and their risk of macrosomia during a full-term pregnancy remains significantly higher after standard treatment.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Tang X, Wei J, Wu S, et al. Fasting blood glucose as a screening measure for late-onset gestational diabetes in the third trimester. BJOG. 2024. PMID: 38952296. doi:10.1111/1471-0528.17897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。